BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35426728)

  • 1. Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals.
    Jalilian AR; Shahi A; Swainson IP; Nakamura H; Venkatesh M; Osso JA
    Cancer Biother Radiopharm; 2022 Jun; 37(5):342-354. PubMed ID: 35426728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
    Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
    Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality.
    Barth RF; Zhang Z; Liu T
    Cancer Commun (Lond); 2018 Jun; 38(1):36. PubMed ID: 29914575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment.
    Coghi P; Li J; Hosmane NS; Zhu Y
    Med Res Rev; 2023 Sep; 43(5):1809-1830. PubMed ID: 37102375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basis and advances in clinical application of boron neutron capture therapy.
    He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
    Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One step synthesis of
    Kuthala N; Shanmugam M; Yao CL; Chiang CS; Hwang KC
    Biomaterials; 2022 Nov; 290():121861. PubMed ID: 36302304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
    Barth RF; Soloway AH; Brugger RM
    Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice.
    Ono K; Masunaga S; Suzuki M; Kinashi Y; Takagaki M; Akaboshi M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):431-6. PubMed ID: 10030272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of sodium borocaptate (BSH) for boron neutron capture therapy (BNCT) in an oral cancer model.
    Garabalino MA; Heber EM; Monti Hughes A; González SJ; Molinari AJ; Pozzi EC; Nievas S; Itoiz ME; Aromando RF; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Radiat Environ Biophys; 2013 Aug; 52(3):351-61. PubMed ID: 23591915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted drug delivery for boron neutron capture therapy.
    Mehta SC; Lu DR
    Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron delivery agents for neutron capture therapy of cancer.
    Barth RF; Mi P; Yang W
    Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.
    Fujimura A; Yasui S; Igawa K; Ueda A; Watanabe K; Hanafusa T; Ichikawa Y; Yoshihashi S; Tsuchida K; Kamiya A; Furuya S
    Cells; 2020 Sep; 9(10):. PubMed ID: 32977522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications.
    Kalot G; Godard A; Busser B; Pliquett J; Broekgaarden M; Motto-Ros V; Wegner KD; Resch-Genger U; Köster U; Denat F; Coll JL; Bodio E; Goze C; Sancey L
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.